共 50 条
- [25] Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma American Journal of Clinical Dermatology, 2022, 23 : 331 - 338
- [29] REHABILITATION OUTCOMES OF LONG-TERM SURVIVORS TREATED FOR HEAD AND NECK-CANCER HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1995, 17 (06): : 503 - 515
- [30] Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141 ONCOLOGIST, 2022, 27 (02): : E194 - E198